Bioreagents for Coagulation/Fibrinolysis Research, Quality Control, Production

• Anti-FIIa Activity, anti-FXa Activity of LMWH in compliance with Pharmacopoeia 8.0.,
  01/ 2014:0828
• NaPPT – Synthetic Phospholipid Reagent for Pharmacopoeia 8.0:2.6.22, Hemocompatibility ISO10993-4
• Activated coagulation Factors in compliance with Pharmacopoeia 2.6.22
• Prekallikrein Activator in compliance with Pharmacopoeia 8.7., 2.6.15.
• Assay of Antithrombin III in compliance with Pharmacopoeia 2.7.17 (coming soon)

For:

• FXIIa
• Thrombin
• Plasminogen
• FXa
• Protein C
• FXIa
• tPA
• ...

• Activated Protein C
• Annexin V
• Antithrombin
• b2GPI
• C4b-BP
• Coagulation Factors VII, FIX, FX, FXa, FXIIa
• Fibrinogen and Fibrinogen Fragmentes D, E, E3t, DD, E
• Tissue Factor, recombinant
• PAI-1
• Plasminogen
• Platelet Factor 4
• Protein C, Protein S, Protein Z
• Prothrombin
• Thrombin
• t-PA, uPA

Coagulation, Hemostasis and Thrombosis related polyclonal antibodies come in various formats: whole (purified) IgG, Affinity Purified IgG, Horseradish Peroxidase conjugated, Fluorescein Isothiocyanate (FITC) conjugated and Biotin conjugated.

Browse our antibodies

• Coagulation Factor Inhibitor Plasmas

They are produced from normal human plasmas from which specific factors have been removed by selective affinity immuno-adsorption and an antibody inhibitory to the specific factor is added to provide neutralizing activity. These products can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors and can be used as positive controls in factor inhibitor assays. RUO.

• Specific coagulation pathway deficient plasmas

Browse our plasmas

• Tissue Factor
• TFPI, Tissue factor Pathway Inhibitor
• Microparticles, extracellular Microvesicles

• CaCl2
• Imidazol buffer
• Phosphate buffer
• Tris-buffer
• Dilution buffer for samples
• Wash Solution for ELISA